Brimonidine Blocks Glutamate Excitotoxicity-Induced Oxidative Stress and Preserves Mitochondrial Transcription Factor A in Ischemic Retinal Injury

Autor: James D. Lindsey, Dongwook Lee, Keunyoung Kim, You Hyun Noh, Robert N. Weinreb, Won-Kyu Ju, Stephen Chai, Mark H. Ellisman
Přispěvatelé: Barnes, Steven
Rok vydání: 2012
Předmět:
Retinal Ganglion Cells
Anatomy and Physiology
genetic structures
Excitotoxicity
lcsh:Medicine
Neurodegenerative
Eye
medicine.disease_cause
Biochemistry
Oxidative Phosphorylation
Energy-Producing Processes
0302 clinical medicine
Ischemia
Receptors
Molecular Cell Biology
Adrenergic alpha-2 Receptor Agonists
lcsh:Science
Energy-Producing Organelles
bcl-2-Associated X Protein
0303 health sciences
Multidisciplinary
Chemistry
Glutamate receptor
Neurochemistry
alpha-2
Signaling Cascades
DNA-Binding Proteins
medicine.anatomical_structure
5.1 Pharmaceuticals
Adrenergic
Brimonidine Tartrate
Cytochemistry
Medicine
Retinal Disorders
bcl-Associated Death Protein
Development of treatments and therapeutic interventions
Neurochemicals
Glutamate
N-Methyl-D-Aspartate
Research Article
Signal Transduction
medicine.medical_specialty
General Science & Technology
Glutamic Acid
Outer plexiform layer
Bioenergetics
Receptors
N-Methyl-D-Aspartate

Retinal ganglion
Neuroprotection
Retina
Stress Signaling Cascade
Mitochondrial Proteins
03 medical and health sciences
Retinal Diseases
Receptors
Adrenergic
alpha-2

Quinoxalines
Internal medicine
medicine
Animals
Eye Disease and Disorders of Vision
Biology
Ganglion cell layer
030304 developmental biology
Superoxide Dismutase
lcsh:R
Neurosciences
Glaucoma
TFAM
Inner plexiform layer
eye diseases
Rats
Oxidative Stress
Ophthalmology
Endocrinology
Cellular Neuroscience
030221 ophthalmology & optometry
lcsh:Q
sense organs
Molecular Neuroscience
Physiological Processes
Energy Metabolism
Transcription Factors
Neuroscience
Zdroj: PLoS ONE
PloS one, vol 7, iss 10
Lee, D; Kim, KY; Noh, YH; Chai, S; Lindsey, JD; Ellisman, MH; et al.(2012). Brimonidine Blocks Glutamate Excitotoxicity-Induced Oxidative Stress and Preserves Mitochondrial Transcription Factor A in Ischemic Retinal Injury. PLoS ONE, 7(10). doi: 10.1371/journal.pone.0047098. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/25s8z7mz
PLoS ONE, Vol 7, Iss 10, p e47098 (2012)
ISSN: 1932-6203
Popis: Glutamate excitotoxicity-induced oxidative stress have been linked to mitochondrial dysfunction in retinal ischemia and optic neuropathies including glaucoma. Brimonindine (BMD), an alpha 2-adrenergic receptor agonist, contributes to the neuroprotection of retinal ganglion cells (RGCs) against glutamate excitotoxicity or oxidative stress. However, the molecular mechanisms of BMD-associated mitochondrial preservation in RGC protection against glutamate excitotoxicity-induced oxidative stress following retinal ischemic injury remain largely unknown. Here, we tested whether activation of alpha 2 adrenergic receptor by systemic BMD treatment blocks glutamate excitotoxicity-induced oxidative stress, and preserves the expression of mitochondrial transcription factor A (Tfam) and oxidative phosphorylation (OXPHOS) complex in ischemic retina. Sprague-Dawley rats received BMD (1 mg/kg/day) or vehicle (0.9% saline) systemically and then transient ischemia was induced by acute intraocular pressure elevation. Systemic BMD treatment significantly increased RGC survival at 4 weeks after ischemia. At 24 hours, BMD significantly decreased Bax expression but increased Bcl-xL and phosphorylated Bad protein expression in ischemic retina. Importantly. BMD significantly blocked the upregulations of N-methyl-D-aspartate receptors 1 and 2A protein expression, as well as of SOD2 protein expression in ischemic retina at 24 hours. During the early neurodegeneration following ischemic injury (12-72 hours), Tfam and OXPHOS complex protein expression were significantly increased in vehicle-treated retina. At 24 hours after ischemia, Tfam immunoreactivity was increased in the outer plexiform layer, inner nuclear layer, inner plexiform layer and ganglion cell layer. Further, Tfam protein was expressed predominantly in RGCs. Finally, BMD preserved Tfam immunoreactivity in RGCs as well as Tfam/OXPHOS complex protein expression in the retinal extracts against ischemic injury. Our findings suggest that systemic BMD treatment protects RGCs by blockade of glutamate excitotoxicity-induced oxidative stress and subsequent preservation of Tfam/OXPHOS complex expression in ischemic retina. © 2012 Lee et al.
Databáze: OpenAIRE